Unibest
← Back to patent-cliff list

CAS 1253955-19-9

(S)-4-(3-((tert-butoxycarbonyl)amino)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate

Codes: NETA-015

Application context (from source-drug indications)

Ocular hypertensionNetarsudil DimesylateOpen-angle glaucomaNetarsudil DimesylateFuchs endothelial corneal dystrophyNetarsudil DimesylateCorneal oedemaNetarsudil DimesylateGlaucomaNetarsudil Dimesylate

Source drugs (routes using this intermediate)

DrugTierExpiry
Netarsudil DimesylateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Netarsudil DimesylateOptimised routesteps: 7total yield: /
methyl 2-[4-(hydroxymethyl)phenyl]acetate→2-((2-carboxy-2-(4-(((triisopropylsilyl)oxy)methyl)phenyl)ethyl)carbamoyl)benzoic acid→(S)-4-(3-((tert-butoxycarbonyl)amino)-1-(isoquinolin-6-ylamino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate→methyl 2-(4-(hydroxymethyl)phenyl)acetate→2,4-dimethylbenzoic acid→4-(2-methoxy-2-oxoethyl)benzyl 2,4-dimethylbenzoate→(R)-5-benzyloxazolidin-2-one→(R)-4-(2-(5-benzyl-2-oxooxazolidin-3-yl)-2-oxoethyl)benzyl 2,4-dimethylbenzoate→tert-butyl ((1H-benzo[d][1,2,3]triazol-1-yl)methyl)carbamate→4-((S)-1-((R)-5-benzyl-2-oxooxazolidin-3-yl)-3-((tert-butoxycarbonyl)amino)-1-oxopropan-2-yl)benzyl 2,4-dimethylbenzoate→(S)-3-((tert-butoxycarbonyl)amino)-2-(4-(((2,4-dimethylbenzoyl)oxy)methyl)phenyl)propanoic acid→1,1,1-trichloro-2-methylpropan-2-yl carbonochloridate

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.